ArriVent BioPharma, Inc. (AVBP) — Shareholders' Equity
| Fiscal Year | Shareholders' Equity | Change YoY |
|---|---|---|
| 2025 | $307.22M | +19.2% |
| 2024 | $257.65M | +268.2% |
| 2023 | -$153.19M | -80.0% |
| 2022 | -$85.11M | — |
| Fiscal Year | Shareholders' Equity | Change YoY |
|---|---|---|
| 2025 | $307.22M | +19.2% |
| 2024 | $257.65M | +268.2% |
| 2023 | -$153.19M | -80.0% |
| 2022 | -$85.11M | — |